uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis
Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden..
Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.;Linkoping Univ, Dept Haematol, Linkoping, Sweden..
Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Medicinsk genetik och genomik.
Show others and affiliations
2015 (English)In: OncoTarget, ISSN 1949-2553, E-ISSN 1949-2553, Vol. 6, no 28, 25109-25120 p.Article in journal (Refereed) Published
Abstract [en]

Telomerase reverse transcriptase gene (TERT) promoter mutations are identified in many malignancies but not in hematological malignancies. Here we analyzed TERT and protection of telomeres 1 gene (POT1) mutations, and four different TERT SNVs in 226 acute myeloid leukemia (AML) patients and 806 healthy individuals in a case referent design, where also overall survival was assessed. A significant association for increased risk of AML was found for TERT SNVs, rs2853669 (OR = 2.45, p = 0.00015) and rs2736100 (OR = 1.5, p = 0.03). The overall survival for patients with CC genotype of rs2853669 was significantly shorter compared to those with TT or TC genotypes (p = 0.036 and 0.029 respectively). The influence of TERT rs2853669 CC on survival was confirmed in multivariable Cox regression analysis as an independent risk biomarker in addition to high risk group, higher age and treatment. No hot spot TERT promoter mutations at -228C>T or -250C>T or POT1 mutations could be identified in this AML cohort. We show that rs2853669 CC may be a risk factor for the development of AML that may also be used as a prognostic marker to identify high risk normal karyotype -AML (NK-AML) patients, for treatment guidance.

Place, publisher, year, edition, pages
2015. Vol. 6, no 28, 25109-25120 p.
Keyword [en]
TERT, SNV, AML, prognostic markers
National Category
Cancer and Oncology Medical Genetics
Identifiers
URN: urn:nbn:se:uu:diva-267332ISI: 000363160100047PubMedID: 26298771OAI: oai:DiVA.org:uu-267332DiVA: diva2:873639
Funder
Swedish Research CouncilSwedish Cancer SocietyAFA Insurance
Available from: 2015-11-24 Created: 2015-11-20 Last updated: 2017-12-01Bibliographically approved

Open Access in DiVA

fulltext(1697 kB)66 downloads
File information
File name FULLTEXT01.pdfFile size 1697 kBChecksum SHA-512
27567ba23bd95cdba6252ae243a7c90e6b24f58f13a2c41bbd199bd4be48fdacb7dc95ac4cd5429bad386de6503b7fe42ccdb905fb0540d9522a62328ea9bdc3
Type fulltextMimetype application/pdf

PubMed

Authority records BETA

Hermanson, MonicaHöglund, Martin

Search in DiVA

By author/editor
Hermanson, MonicaHöglund, Martin
By organisation
Medicinsk genetik och genomikHaematology
In the same journal
OncoTarget
Cancer and OncologyMedical Genetics

Search outside of DiVA

GoogleGoogle Scholar
Total: 66 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 377 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf